Matthew P. Young's Net Worth
$9.79 Million
Who is Matthew P. Young?
Matthew P. Young has an estimated net worth of $9.79 Million. This is based on reported shares across multiple companies, which include Jazz Pharmaceuticals plc, PRA Health Sciences, Inc., and CytomX Therapeutics, Inc..
SEC CIK
Matthew P. Young's CIK is 0001601583
Past Insider Trading and Trends
2018 was Matthew P. Young's most active year for acquiring shares with 6 total transactions. Matthew P. Young's most active month to acquire stocks was the month of May. 2018 was Matthew P. Young's most active year for disposing of shares, totalling 25 transactions. Matthew P. Young's most active month to dispose stocks was the month of January. 2018 saw Matthew P. Young paying a total of $293,600.00 for 53,207 shares, this is the most they've acquired in one year. In 2018 Matthew P. Young cashed out on 27,056 shares for a total of $3,482,257.44, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.43% | -3.77K |
$135.69 | -$511,161.62 | 36.2K |
Scheduled
|
Mar 5 - Mar 6
| ||
Form 4
| +42.91% | 12K |
—
|
—
| 39.97K |
Feb 28
| |||
Form 4
| -12.97% | -4.17K |
$129.02 | -$537,748.54 | 27.97K |
Scheduled
|
Feb 25 - Feb 27
| ||
Form 4
| -2.14% | -700.00 |
$150.00 | -$105,000.00 | 32.07K |
Scheduled
|
Nov 23
| ||
Form 4
| -2.09% | -700.00 |
$158.08 | -$110,657.96 | 32.77K |
Scheduled
|
Oct 15
| ||
Form 4
| -2.05% | -700.00 |
$162.70 | -$113,890.00 | 33.47K |
Scheduled
|
Sep 17
| ||
Form 4
| -2.01% | -700.00 |
$176.05 | -$123,235.00 | 34.17K |
Scheduled
|
Aug 15
| ||
Form 4
| -1.97% | -700.00 |
$176.06 | -$123,242.00 | 34.87K |
Scheduled
|
Jul 16
| ||
Form 4
| -1.93% | -700.00 |
$176.99 | -$123,893.00 | 35.57K |
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
$114.38 | -$556,612.00 | 36.27K |
Scheduled
|
Jun 1
| ||
Form 4
| -5.88% | -2.26K |
$165.15 | -$373,560.80 | 36.2K |
Scheduled
|
May 14 - May 15
| ||
Form 4
| -1.79% | -700.00 |
$156.01 | -$109,207.00 | 38.47K |
Scheduled
|
Apr 16
| ||
Form 4
| -1.76% | -700.00 |
$151.22 | -$105,854.00 | 39.16K |
Scheduled
|
Mar 15
| ||
Form 4
| -5.90% | -2.50K |
$142.92 | -$357,288.01 | 39.87K |
Scheduled
|
Mar 5 - Mar 6
| ||
Form 4
| +28.52% | 9.4K |
—
|
—
| 42.37K |
Mar 1
| |||
Form 4
| -15.39% | -5.99K |
$146.76 | -$879,705.66 | 32.97K |
Scheduled
|
Feb 26 - Feb 28
| ||
Form 4
| -1.77% | -700.00 |
$152.16 | -$106,512.00 | 38.96K |
Scheduled
|
Jan 16
| ||
Form 4
| -2.02% | -815.00 |
$153.79 | -$125,338.85 | 39.53K |
May 12
| |||
Form 4
| -3.73% | -1.56K |
$158.38 | -$247,864.70 | 40.35K |
May 3
| |||
Form 4
| +31.34% | 10K |
—
|
—
| 41.91K |
Mar 2
| |||
Form 4
| -5.88% | -1.99K |
$136.97 | -$273,118.18 | 31.91K |
Feb 27
| |||
Form 4
| -2.35% | -815.00 |
$145.23 | -$118,362.45 | 33.81K |
May 12
| |||
Form 4
| -3.29% | -1.18K |
$152.47 | -$179,457.19 | 34.62K |
May 3
| |||
Form 4
| -1.17% | -422.00 |
$121.58 | -$51,306.76 | 35.8K |
Feb 29
| |||
Form 4
| +29.55% | 8.26K |
$125.00 | -$92,125.00 | 36.22K |
Feb 25 - Feb 26
| |||
Form 4
| -2.81% | -801.00 |
$176.60 | -$141,456.60 | 27.66K |
May 12
| |||
Form 4
| -3.81% | -1.13K |
$183.23 | -$206,500.21 | 28.46K |
May 4
| |||
Form 4
| +32.38% | 7.24K |
$170.09 | -$74,329.33 | 29.59K |
Feb 26 - Feb 27
| |||
Form 4
| +39.99% | 6.25K |
—
|
—
| 21.88K |
May 12
| |||
Form 4
| -6.73% | -1.13K |
$141.98 | -$160,011.46 | 15.63K |
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRA Health Sciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.13K |
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +3.64% | 250 |
—
|
—
| 7.13K |
Jun 1
| |||
Form 4
| +23.84% | 1.32K |
—
|
—
| 6.88K |
May 18
| |||
Form 4
| +34.88% | 1.44K |
—
|
—
| 5.55K |
Jun 3
| |||
Form 4
| +46.51% | 1.31K |
—
|
—
| 4.12K |
Jun 21
| |||
Form 4
| -64.54% | -5.12K |
$79.90 | -$408,688.50 | 2.81K |
Nov 14 - Nov 16
| |||
Form 4
| +19.95% | 1.32K |
—
|
—
| 7.92K |
Jul 12
| |||
Form 4
| +82.31% | 2.98K |
—
|
—
| 6.61K |
Jun 17
| |||
Form 4
|
∞
| 3.62K |
—
|
—
| 3.62K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||